European Association for Cancer Research (EACR) shared a post on LinkedIn:
“Irene Casanova Salas was the 2024 recipient of an EACR-AstraZeneca Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe and the world.
Learn more about the progress she’s made in her research into monitoring adaptive transcriptomic changes during therapy resistance and disease progression using a novel extracellular vesicle (EV)-based liquid biopsy assay in The Cancer Researcher”
Other articles about European Association for Cancer Research on OncoDaily.